BIOMAT Database Logo BIOMAT Database Logo

Comparison of hyperlipidemia in dialysis patients, renal transplant recipients, and steroid treated nonrenal patients. 1980

N D Vaziri, and C Risk, and D C Martin, and H S Novey

Serum lipids were studied in 25 stable renal transplant recipients 3-60 months after transplantation, 25 stable patients maintained on hemodialysis, and 16 steroid-treated patients with normal renal functions. Lipid abnormalities were found in 72% of the transplant patients and 52% of dialysis patients. The mean serum triglyceride levels were significantly higher in the transplant and the dialysis group than age and sex matched controls, but were not significantly elevated in the steroid-treated patients with normal renal function. The mean cholesterol levels were normal for the transplant and steroid-treated groups, but significantly reduced in the dialysis group. There was a significant correlation between the triglyceride levels and the reciprocal of creatinine clearance suggestive of a possible etiologic relationship.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

N D Vaziri, and C Risk, and D C Martin, and H S Novey
Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin).
May 1998, Transplantation,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Posttransplantation chronic renal damage in nonrenal transplant recipients.
October 2005, Kidney international,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Steroid minimization for sirolimus-treated renal transplant recipients.
January 2011, Clinical transplantation,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Hyperlipidemia in stable renal transplant recipients.
August 1994, Transplantation proceedings,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Hyperlipidemia in stable renal transplant recipients.
January 1991, Nephron,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Treatment of hyperlipidemia in renal transplant recipients.
February 1997, Transplantation,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.
September 1993, JAMA,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Home dialysis is a successful strategy in nonrenal solid organ transplant recipients with end-stage renal disease.
October 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
Comparison of erythrocyte membrane fatty acid contents in renal transplant recipients and dialysis patients.
December 2012, Transplantation proceedings,
N D Vaziri, and C Risk, and D C Martin, and H S Novey
[Treatment of hypertension in dialysis patients and renal transplant recipients].
January 2005, Przeglad lekarski,
Copied contents to your clipboard!